Acarbose
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| PD-Rx Pharmaceuticals, Inc. | repackager | 12 | SUPPLYING |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | generic | 9 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 6 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | generic | 3 | SUPPLYING |
| Chartwell RX, LLC | generic | 3 | SUPPLYING |
| Strides Pharma Science Limited | generic | 3 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Subpotent Drug: The firm received an out of specification result for Assay (potency was below specification) at the 9 month stability time point. — Recalling firm: Boehringer Ingelheim Roxane Inc — Nationwide and Puerto Rico
